NeoPhore ^Companies

NeoPhore is a provider of novel small molecule therapies that aim to treat cancer by stimulating the immune system. Their therapies target genetic mechanisms to create neoantigens, which stimulate the immune system and weaken tumor cell defenses. NeoPhore's goal is to develop effective and well-tolerated medicines that will be a crucial part of the next generation of cancer immunotherapies. Their approach has shown robust and sustained immune responses against certain cancers lacking DNA mismatch repair genes.